Progyny (PGNY)
(Delayed Data from NSDQ)
$22.52 USD
+0.89 (4.11%)
Updated Sep 18, 2025 04:00 PM ET
After-Market: $22.52 0.00 (0.00%) 6:14 PM ET
3-Hold of 5 3
B Value A Growth A Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
PGNY 22.52 +0.89(4.11%)
Will PGNY be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for PGNY based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for PGNY
Surging Earnings Estimates Signal Upside for Progyny (PGNY) Stock
CVS Health Corporation (CVS) Hit a 52 Week High, Can the Run Continue?
PGNY: What are Zacks experts saying now?
Zacks Private Portfolio Services
Progyny (PGNY) Tops Q2 Earnings and Revenue Estimates
Agilon Health (AGL) Reports Q2 Loss, Misses Revenue Estimates
BrightSpring Health Services, Inc. (BTSG) Q2 Earnings and Revenues Beat Estimates
Other News for PGNY
Is PGNY building bearish momentum? Lower Bollinger Band Walk shows up after sliding 0.64%
PGNY forms Directional Movement Crossover Bearish on September 16
PGNY forms Bollinger Band Squeeze on September 15
Fell Below 20 Day Moving Average appears for PGNY after 2.85% move
PGNY Crossed Above 20 Day Moving Average on September 11